Dowling Oration 2001Evidence-based dermatology − a bridge too far?
H. Williams,
H. Williams
Search for more papers by this authorH. Williams,
H. Williams
Search for more papers by this author
References
- 1 Kernick DP. Lies. damned lies, and evidence-based medicine. Lancet 1998; 351: 1824.
- 2 Feinstein AR & Horwitz RI. Problems in the ‘evidence’ of ‘evidence-based medicine’. Am J Med 1997; 103: 529–35.DOI: 10.1016/S0002-9343(97)00244-1
- 3 Guyatt GH, Haynes RB, Jaeschke RZ et al. Users' guides to the medical literature: XXV. Evidence-based medicine: principles for applying the Users' Guides to patient care. Evidence-Based Medicine Working Group. JAMA 2000; 284: 1290–6.
- 4 Rosenberg W & Donald A. Evidence based medicine: an approach to clinical problem-solving. BMJ 1995; 310: 1122–6.
- 5 Sackett DL, Richardson WS, Rosenberg Q, Haynes RB. Evidence-based Medicine. How to Practice and Teach EBM. London:Churchill Livingstone, 1997.
- 6 Rees J. Evidence-based medicine: the epistemology that isn't. J Am Acad Dermatol 2000; 43: 727–9.
- 7 Greenhalgh T. How to Read a Paper. London: BMJ Publishing Group, 1997.
- 8 Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ 1996; 312: 71–2.
- 9 Bigby M. Snake oil for the 21st century. Arch Dermatol 1998; 134: 1512–4.
- 10 Griffiths CEM, Clark CM, Chalmers RJG, Li Wan Po A, Williams HC. A systematic review of treatments for severe psoriasis. Health Technol Assess 2000; 4 (40).
- 11 Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000; 4 (37).
- 12 Seidman D. Compliance with guidelines is not the same as evidence-based medicine. J Pediatrics 2001; 138: 299–300.
- 13 Merkel R. The tension between the quest for sameness and the valuing of difference: evidence-based medicine in the 21st Century. Clin Dermatol 2001; 19: 23–6.DOI: 10.1016/S0738-081X(00)00204-2
- 14 Echt DS, Liebson PR, Mitchell LB et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Eng J Med 1991; 324: 781–8.
- 15 Al-Suwaidan SN & Feldman SR. Clearance is not a realistic expectation of psoriasis treatment. J Am Acad Dermatol 2000; 42: 796–802.
- 16 Wollenberg A, Kraft S, Oppel T, Bieber T. Atopic dermatitis: pathogenetic mechanisms. Clin Exp Dermatol 2000; 25: 530–4.DOI: 10.1046/j.1365-2230.2000.00699.x
- 17 Straus SE & Sackett DL. Bringing evidence to the clinic. Arch Dermatol 1998; 134: 1519–20.
- 18 Malone SM. Knowledge management: white knight or white elephant? Topics Health Information Manage 2001; 21: 33–43.
- 19 Smith R. Where is the wisdom? BMJ 1992; 303: 798–9.
- 20 Camisa C. Psoriasis. Cambridge, Mass: Blackwell Scientific Publications Inc., 1994.
- 21 Owen CM, Chalmers RJG, O'Sullivan T, Griffiths CEM. Antistreptococcal Interventions for Guttate and Chronic Plaque Psoriasis (Cochrane Review). In: The Cochrane Library, Issue 3. Oxford: Update Software, 2001.
- 22 Delamere FM & Williams HC. How can hand searching the dermatological literature help people with skin problems? Arch Dermatol 2001; 137: 332–5.
- 23 Adetugbo K & Williams H. How well are randomized controlled trials reported in the dermatology literature? Arch Dermatol 2000; 136: 381–5.
- 24 The Cochrane Library, Issue 3. Oxford: Update Software, 2001.
- 25 Shaughnessy AF, Slawson DC, Bennett JH. Becoming an information master: a guidebook to the medical information jungle. J Fam Prac 1994; 39: 489–99.
- 26 Bigby M. Evidence-based medicine in dermatology. Dermatologic Clin 2000; 18: 261–76.
- 27 Li Wan Po A & Williams HC. Collating the evidence. In: HC Williams, DP Strachan, eds. The Challenge of Dermato-Epidemiology. Boca Raton: CRC Press Inc., 1997: 99–108.
- 28 Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992; 327: 248–54.
- 29 Williams H, Adetugbo K, Po AL, Naldi L, Diepgen T, Murrell D. The Cochrane Skin Group. Preparing, maintaining, and disseminating systematic reviews of clinical interventions in dermatology. Arch Dermatol 1998; 134: 1620–6.
- 30 Gibbs S, Harvey I, Sterling JC, Stark R. Local treatments for cutaneous (Cochrane Review). In: The Cochrane Library, Issue 3. Oxford: Update Software, 2001.
- 31 Ladhani S & Williams HC. The management of established postherpetic neuralgia: a comparison of the quality and content of traditional vs. systematic reviews. Br J Dermatol 1998; 139: 66–72.
- 32 Williams HC. Atopic eczema – we should look to the environment. BMJ 1995; 311: 1241–2.
- 33 Sackett DL & Wennberg JE. Choosing the best research design for each question. BMJ 1997; 315: 1636.
- 34 Barton S. Which clinical studies provide the best evidence? The best RCT still trumps the best observational study. BMJ 2000; 321: 255–6.DOI: 10.1136/bmj.321.7256.255
- 35 Bigby M. Challenges to the hierarchy of evidence: does the emperor have no clothes? Arch Dermatol 2001; 137: 345–6.
- 36 Hill D. Efficacy of sunscreens in protection against skin cancer. Lancet 1999; 354: 699–700.
- 37 Juni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. BMJ 2001; 323: 42–6.
- 38 Mant D. Can randomised trials inform clinical decisions about individual patients? Lancet 1999; 353: 743–6.
- 39 Li Wan Po A. Dictionary of Evidence-Based Medicine. Oxford: Radcliffe Medical Press, 1998.
- 40 Virag R. Indications and early results of sildenafil (Viagra) in erectile dysfunction. Urology 1999; 54: 1073–7.
- 41 Bakan D. The general and the aggregate: a methodological distinction. Perceptual Motor Skills 1955; 5: 211–2.
- 42 Valsiner J. Between groups and individuals. In: J Valsiner, ed. The Individual Subject and Scientific Psychology. London: Plenum Press, 1985: 113–151.
- 43 Nikles CJ, Glasziou PP, Del March CB, Duggan CM, Mitchell G. N of 1 trials. Practical tools for medication management. Aust Family Physician 2000; 29: 1108–12.
- 44 Charman C & Williams H. Outcome measures of disease severity in atopic eczema. Arch Dermatol 2000; 136: 763–9.
- 45 Olsen EA. Topical minoxidil in the treatment of androgenetic alopecia in women. Cutis 1991; 48: 243–8.
- 46 Hollis S & Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 1999; 319: 670–4.
- 47 Eypasch E, Lefering R, Kum CK, Troidl H. Probability of adverse events that have not yet occurred: a statistical reminder. BMJ 1995; 311: 619–20.
- 48 Shaughnessy AF, Slawson DC, Becker L. Clinical jazz: harmonizing clinical experience and evidence-based medicine. J Fam Prac 1998; 47: 425–8.
- 49 Mariotto A. Alternatives to evidence based medicine. Propaganda based medicine is an alternative. BMJ 2000; 321: 239.DOI: 10.1136/bmj.321.7255.239
- 50 Dobbie AE, Schneider FD, Anderson AD, Littlefield J. What evidence supports teaching evidence-based medicine? Academic Med 2000; 75: 1184–5.
- 51 Straus SE & McAlister FA. Evidence-based medicine: a commentary on common criticisms. CMAJ 2000; 163: 837–41.
- 52 Gibbs S. Losing touch with the healing art: dermatology and the decline of pastoral doctoring. J Am Acad Dermatol 2000; 43: 875–8.
- 53 Williams HC & Seed P. Inadequate size of ‘negative’ clinical trials in dermatology. Br J Dermatol 1993; 128: 317–26.
- 54 Cox NH & Williams HC. Can you COPE with CONSORT? Br J Dermatol 2000; 142: 1–3.
- 55 Williams HC & Monk B. Creeping eruption stopped in its tracks by albendazole. Clin Exp Dermatol 1989; 14: 355–6.
- 56 Caumes E, Carriere J, Datry A, Gaxotte P, Danis M, Gentilini M. A randomized trial of ivermectin versus albendazole for the treatment of cutaneous larva migrans. Am J Trop Med Hyg 1993; 49: 641–4.
